EMGRAST M 500MCG INJECTION belongs to the class of medications called colony-stimulating factors used to treat neutropenia, a deficiency of specific white blood cells caused by cancer, bone marrow transplant, chemotherapy, or other diseases. EMGRAST M 500MCG INJECTION helps reduce the chance of infection in cancer patients and those receiving chemotherapy medicines. Neutropenia is a condition in which the quantity of neutrophils (white blood cells) in the blood is reduced.
EMGRAST M 500MCG INJECTION contains Sargramostim, a growth factor that stimulates the formation of white blood cells and helps reduce the chances of infection in cancer patients receiving chemotherapy.
A healthcare professional will administer EMGRAST M 500MCG INJECTION. Sometimes, you may experience injection site responses such as pain, redness, or swelling. You may also experience nausea, vomiting, headache, diarrhoea, stomach pain, mouth sores, loss of appetite, hair loss and bone, joint, or muscle pain. Most of these side effects do not necessitate medical treatment and will gradually fade over time. However, if you suffer these side effects regularly, you should consult your doctor.
It is not suggested to use EMGRAST M 500MCG INJECTION in those who have had severe allergic responses, including anaphylaxis, to human granulocyte-macrophage colony-stimulating factor, yeast-derived products, or any component of EMGRAST M 500MCG INJECTION. To rule out any negative effects, keep your doctor informed about your medical condition and all medications you take. Inform your doctor if you are pregnant, intend to become pregnant, or are currently breastfeeding. Contact your doctor if you become pregnant while using EMGRAST M 500MCG INJECTION.